SCHEMBL23745825

SCHEMBL23745825

Cc1cccc(C(CCNC2CCN(C(N)=O)CC2)c2cn(C3CCCCC3)c3ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.38
MAPT P10636 4/20 0.37
CCR2 P41597 1/20 0.37
CTDSP1 Q9GZU7 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
C3AR1 Q16581 1/20 0.36
TPSAB1 Q15661 2/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
CCR5 P51681 1/20 0.34
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
OPRL1 P41146 1/20 0.33
REN P00797 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL23722146 0.99 MEN1 (0.38) MEN1KMT2AKDM4EMAPTCCR2
SCHEMBL23721997 0.93 CCR2 (0.39) MEN1KMT2AKDM4EMAPTCCR2
SCHEMBL23745770 0.92 TPSAB1 (0.35) MEN1KMT2AKDM4EMAPTCCR2
Hydrochloric Acid SCHEMBL23721888 0.91 TPSAB1 (0.35) MEN1KMT2AKDM4EMAPTCCR2
SCHEMBL23745780 0.90 KMT2A (0.39) MEN1KMT2AKDM4EMAPTCCR2
SCHEMBL23722076 0.90 KMT2A (0.39) MEN1KMT2AKDM4EMAPTCCR2
SCHEMBL23745472 0.87 MPO (0.36) MEN1KMT2AKDM4EMAPTCCR2
SCHEMBL23745631 0.87 MPO (0.36) MEN1KMT2AKDM4EMAPTCCR2
Hydrochloric Acid SCHEMBL23722007 0.86 MPO (0.36) MEN1KMT2AKDM4EMAPTCCR2
SCHEMBL23745754 0.86 SOS1 (0.36) MEN1KMT2AKDM4EMAPTCCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF BIOIMICS AB (SE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246115-A1 ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF FDPS, FPR1, F12 MEN1 894/4885KMT2A 4684/4885KDM4E 4474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.